title: Combined use of autografting and non-myeloablative allografting for the treatment of hematologic malignancies and metastatic breast cancer.
authors.affiliation: Department Hematology-Oncology, Ospedale Casa Sollievo Della Sofferenza, Irccs San Giovanni Rotondo, Fg., Italy.
authors.forename: Angelo M
authors.initials: AM
authors.lastname: Carella
authors.forename: Germana
authors.initials: G
authors.lastname: Beltrami
authors.forename: Enrica
authors.initials: E
authors.lastname: Lerma
authors.forename: Marina
authors.initials: M
authors.lastname: Cavaliere
authors.forename: Maria T
authors.initials: MT
authors.lastname: Corsetti
mesh_terms: D001943:Breast Neoplasms / Q000628:therapy*; D005260:Female; D006086:Graft vs Host Disease / Q000517:prevention & control; D019337:Hematologic Neoplasms / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D019172:Transplantation Conditioning / Q000379:methods*; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous; D014740:Vidarabine / Q000031:analogs & derivatives / Q000494:pharmacology
chemical_list: D014740:Vidarabine; C024352:fludarabine